AbbVie Inc (ABBV)

NYSE
में मुद्रा USD
अस्वीकरण
153.26
-0.65(-0.42%)
रियल टाइम डेटा
दिन की रेंज
151.61154.00
52 सप्ताह रेंज
130.96168.11
पिछला बंद
153.91
खुला
153.63
दिन की रेंज
151.61-154
52 सप्ताह रेंज
130.96-168.11
वॉल्यूम
2,168,344
औसत वॉल्यूम (3एम)
4,796,980
1- वर्ष बदलाव
8.99%
बकाया शेयर
1,765,046,680
विश्लेषक
तकनीकी
मजबूत विक्रय
बेचना
तटस्थ
खरीदें
मजबूत खरीद
मजबूत विक्रय

लोग इसे भी देखते हैं

548.88
LLY
-0.21%
157.47
JNJ
-0.97%
41.86
MO
-0.09%
207.49
LOW
-0.50%
110.08
TGT
+0.55%

AbbVie Inc कंपनी प्रोफाइल

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn’s disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

क्षेत्र
हेल्थकेयर
कर्मचारी
50000

आय विवरण